Cml
Monitoring CML Treatment: Addressing the Issues for the Community Hematologist/Oncologist
Chronic myeloid leukemia. ● The myeloproliferative diseases (MPDs) are clonal stem cell disorders characterised by leukocytosis, thrombocytosis, erythrocytosis,
Monitoring CML Treatment: Addressing the Issues for the Community Hematologist/Oncologist Hagop M. Kantarjian, MD Chairman; Professor, Department of Leukemia.
